Thursday, October 01, 2020 3:10:42 AM
But cappy was right to focus on a detail of the 8-K: that the purchaser is technically FiveT Capital Holdings AG.
This is specifically the FiveT Capital Holding AG which bought and sold large activist investments in PLUG and American Apparel etc., and just a couple weeks ago, just 1 day before the NVSOS filings started hitting, made a convertible loan to a NASDAQ-listed company, Auris Medical, to support the development of its Covid product I've posted about a few times.
This is the wing that's actively investing, lending, and making the real money. We don't have all the details of their holdings and activities, because as a private company in Switzerland, they only need to do SEC filings for SEC-filing companies (i.e. they don't have to disclose to the SEC stakes in stocks that only trade on European exchanges. So we're not privy to what else they may have their hands in.
But here's what cappy doesn't know: the *parent company* is FiveT Capital Holdings AG, which just took control of $QUTR, while its wholly owned subsidiary is FiveT Capital AG. I think he thought it was the other way around and that he'd gotten me.
All I can say is that it would be a grand thing to be on the money-making side of convertible lending, and to have the advantage of buying into major companies at institutional placement discount prices. It's looking like a gold mine. Have you ever held a stock only to learn that an institutional investor just bought the same shares for 50% of the price you did? That's the advantage of being an institutional investor. Have you ever held a stock but the lender of the convertible note not only got monthly interest payments but also got to convert shares at a huge discount? FiveT Holdings is on the money-making side of that equation too.
All my opinion of course :)
Now cappy, you were finally right about something, sort of--by inference but for the wrong reason--for the first time in the 232 posts that remain. And I acknowledged it immediately as any decent person should. It's easy and builds character.
H
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM